Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartolomé Celli

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
ERJ Open Research|December 20, 2017
Natural history of COPD: gaps and opportunitiesAlvar Agustí, Bartolomé Celli
American Journal of Respiratory and Critical Care Medicine|December 21, 2010
Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicineAlvar Agusti, Patricia Sobradillo, Bartolomé Celli
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Impact and prevention of severe exacerbations of COPD: a review of the evidenceDavid Mg Halpin, Marc Miravitlles, Norbert Metzdorf, et al.
Archivos De Bronconeumologia|March 21, 2022
The 7 Cardinal Sins of COPD in SpainJosé Luis Izquierdo, Ciro Casanova, Bartolomé Celli, et al.
ERJ Open Research|July 13, 2026
Eosinophil subtypes in asthmatic patients treated with mepolizumab, omalizumab and dupilumabCarlos Cabrera López, Alejandra Sánchez Santos, Angelina Lemes Castellano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2023
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologistsAlvar Agusti, Michael Böhm, Bartolomé Celli, et al.
Archivos De Bronconeumologia|May 13, 2017
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary DiseaseJuan Antonio Riesco Miranda, Bernardino Alcázar, Inmaculada Alfageme, et al.
Respiratory Medicine|May 5, 2018
Shorter telomeres in non-smoking patients with airflow limitationElizabeth Córdoba-Lanús, Carlos Cabrera-López, Sara Cazorla-Rivero, et al.
The Clinical Respiratory Journal|December 17, 2010
Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH studyJørgen Vestbo, Julie Anne Anderson, Peter Mark Anthony Calverley, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2011
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whitesShannon Bruse, Akshay Sood, Hans Petersen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
ERJ Open Research|December 20, 2017
Natural history of COPD: gaps and opportunitiesAlvar Agustí, Bartolomé Celli
American Journal of Respiratory and Critical Care Medicine|December 21, 2010
Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicineAlvar Agusti, Patricia Sobradillo, Bartolomé Celli
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Impact and prevention of severe exacerbations of COPD: a review of the evidenceDavid Mg Halpin, Marc Miravitlles, Norbert Metzdorf, et al.
Archivos De Bronconeumologia|March 21, 2022
The 7 Cardinal Sins of COPD in SpainJosé Luis Izquierdo, Ciro Casanova, Bartolomé Celli, et al.
ERJ Open Research|July 13, 2026
Eosinophil subtypes in asthmatic patients treated with mepolizumab, omalizumab and dupilumabCarlos Cabrera López, Alejandra Sánchez Santos, Angelina Lemes Castellano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2023
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologistsAlvar Agusti, Michael Böhm, Bartolomé Celli, et al.
Archivos De Bronconeumologia|May 13, 2017
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary DiseaseJuan Antonio Riesco Miranda, Bernardino Alcázar, Inmaculada Alfageme, et al.
Respiratory Medicine|May 5, 2018
Shorter telomeres in non-smoking patients with airflow limitationElizabeth Córdoba-Lanús, Carlos Cabrera-López, Sara Cazorla-Rivero, et al.
The Clinical Respiratory Journal|December 17, 2010
Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH studyJørgen Vestbo, Julie Anne Anderson, Peter Mark Anthony Calverley, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2011
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whitesShannon Bruse, Akshay Sood, Hans Petersen, et al.
Pageof 3